Heron Therapeutics | DEF 14A: Definitive information statements
Apr 30 02:38
Heron Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Apr 20 05:25
Heron Therapeutics | 8-K: Current report
Mar 22 04:38
Heron Therapeutics | 8-K: Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates
Mar 13 04:15
Heron Therapeutics | 8-K: Current report
Jan 24 21:04
Heron Therapeutics | 8-K: Current report
Jan 11 13:00
Heron Therapeutics | 8-K: Current report
Dec 23, 2023 05:30
Heron Therapeutics | 8-K: Current report
Dec 22, 2023 06:25
Heron Therapeutics | 8-K: Heron Therapeutics Announces Third Quarter 2023 Financial Results and Updates Financial Guidance
Nov 15, 2023 05:10
Heron Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Aug 24, 2023 04:08
Heron Therapeutics | 8-K: Heron Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Updates
Aug 15, 2023 04:11
Heron Therapeutics | 8-K: Current report
Jul 24, 2023 21:12
Heron Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Jul 1, 2023 04:06
Heron Therapeutics | 8-K: Current report
Jun 24, 2023 04:19
Heron Therapeutics | 8-K: Current report
Jun 12, 2023 21:10
Heron Therapeutics | 8-K: Current report
May 12, 2023 04:06
Heron Therapeutics | DEF 14A: Definitive proxy statements
May 1, 2023 21:00
Heron Therapeutics | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition
Apr 21, 2023 04:06
Heron Therapeutics | 8-K: Current report
Apr 20, 2023 21:10
Heron Therapeutics | 8-K: Current report
Apr 3, 2023 21:10
No Data
No Data